CAMPATH Side Effects

6763402-4 | Cellulitis, Oral Herpes
on May 26, 2010 Female patient from UNITED STATES , 39 years of age, weighting 207.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), prophylaxis and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), oral herpes. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with ACYCLOVIR (Total Daily Dose: 400 Mg) (View Acyclovir Review and Acyclovir Label ), REBIF (Total Daily Dose: 44 ?g) (View Rebif Review and Rebif Label ). Patient was hospitalized.

6762466-1 | Agitation, Blood Creatinine Increased, Blood Potassium Decreased, Carbon Dioxide Decreased, Cardiac Failure Congestive, Disorientation, Dyspnoea, Enterobacter Sepsis, Hallucination, Auditory
Patient was taking Campath (View Usage). Patient had the following side effects: agitation, blood creatinine increased, blood potassium decreased, carbon dioxide decreased, cardiac failure congestive, disorientation, dyspnoea, enterobacter sepsis, hallucination, auditory on Jun 07, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 145.5 lb, was diagnosed with bone marrow conditioning regimen and. Campath dosage: Total Daily Dose: 20 Mg. During the same period patient was treated with CLOFARABINE (Total Daily Dose: 76 Mg/m2 Unit Dose: 40 Mg/m2) (View Clofarabine Review and Clofarabine Label ), MELPHALAN (Total Daily Dose: 266 Mg) (View Melphalan Review and Melphalan Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), IRON SULFATETHIAMIN COMPOUND TAB (View Iron Sulfatethiamin Compound Tab Review and Iron Sulfatethiamin Compound Tab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6762465-X | Renal Failure
Adverse event was reported on Jun 07, 2010 by a Female patient taking Campath (View Usage) (Dosage: Total Daily Dose: 20 Mg) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 45 years of age, After Campath was administered, patient had the following side effects: renal failure. During the same period patient was treated with CLOFARABINE (View Clofarabine Review and Clofarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6761712-8 | Agitation, Blood Creatinine Increased, Blood Potassium Decreased, Carbon Dioxide Decreased, Cardiac Failure Congestive, Disorientation, Dyspnoea, Enterobacter Sepsis, Hallucination, Auditory
on Jun 07, 2010 Female patient from UNITED STATES , 69 years of age, weighting 145.5 lb, was diagnosed with bone marrow conditioning regimen and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, blood creatinine increased, blood potassium decreased, carbon dioxide decreased, cardiac failure congestive, disorientation, dyspnoea, enterobacter sepsis, hallucination, auditory. Campath dosage: Total Daily Dose: 20 Mg. During the same period patient was treated with CLOFARABINE (Total Daily Dose: 76 Mg/m2 Unit Dose: 40 Mg/m2) (View Clofarabine Review and Clofarabine Label ), MELPHALAN (Total Daily Dose: 266 Mg) (View Melphalan Review and Melphalan Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), IRON SULFATETHIAMIN COMPOUND TAB (View Iron Sulfatethiamin Compound Tab Review and Iron Sulfatethiamin Compound Tab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.


6761711-6 | Renal Failure
on Jun 07, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with acute myeloid leukaemia and was treated with Campath (View Usage). Patient had the following side effects: renal failure. Campath dosage: Total Daily Dose: 20 Mg. During the same period patient was treated with CLOFARABINE (View Clofarabine Review and Clofarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6759943-6 | Acute Graft Versus Host Disease In Liver, Acute Graft Versus Host Disease In Skin, Blood Lactate Dehydrogenase Increased, Febrile Neutropenia, Glucose Tolerance Impaired, Haemolysis, Hyperbilirubinaemia, Microangiopathy
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, blood lactate dehydrogenase increased, febrile neutropenia, glucose tolerance impaired, haemolysis, hyperbilirubinaemia, microangiopathy on May 28, 2010 from PAKISTAN Additional patient health information: Male patient , 42 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and. Campath dosage: 3 Cycles. During the same period patient was treated with FLUDARABINE (3 Cycles) (View Fludarabine Review and Fludarabine Label ), MELPHALAN (3 Cycles) (View Melphalan Review and Melphalan Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6759942-4 | Central Nervous System Lymphoma, Epstein-barr Virus Associated Lymphoproliferative Disorder, Hydrocephalus, Somnolence, Vomiting
Adverse event was reported on May 29, 2010 by a Male patient taking Campath (View Usage) (Dosage: ) was diagnosed with stem cell transplant, congenital white blood cell disorder and. Location: UNITED KINGDOM , child 4 years of age, Patient experienced the following unwanted or unexpected effects: central nervous system lymphoma, epstein-barr virus associated lymphoproliferative disorder, hydrocephalus (What is hydrocephalus?), somnolence, vomiting. During the same period patient was treated with FLUDARABINE (View Fludarabine Review and Fludarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), DEXAMETHASONE (Hlh-2004 Protocol) (View Dexamethasone Review and Dexamethasone Label ), ETOPOSIDE (Hlh-2004 Protocol) (View Etoposide Review and Etoposide Label ), CYCLOSPORINE (Hlh-2004 Protocol) (View Cyclosporine Review and Cyclosporine Label ).

6759811-X | Lung Disorder, Pyrexia
on May 20, 2010 Female patient from UNITED KINGDOM , 34 years of age, was treated with Campath (View Usage). Patient had the following side effects: lung disorder, pyrexia. Campath dosage: Day 1. During the same period patient was treated with DOXORUBICIN HCL (Day 1) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Day 1, (maximum 2.0 Mg)) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (Day 1) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (Days 1-5) (View Prednisone Review and Prednisone Label ), METHOTREXATE (Day 1) (View Methotrexate Review and Methotrexate Label ), ARA C (Day 1) (View Ara-c Review and Ara-c Label ), DEXAMETHASONE (Day 1) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6758674-6 | Back Pain, Nephrolithiasis, Vomiting
on May 24, 2010 Male patient from UNITED STATES , 28 years of age, weighting 174.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: back pain (What is back pain?), nephrolithiasis, vomiting. Campath dosage: Total Daily Dose: 12 Mg. Patient was hospitalized.

6755672-3 | Lung Disorder, Pyrexia
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder, pyrexia on May 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 34 years of age, . Campath dosage: Day 1. During the same period patient was treated with DOXORUBICIN HCL (Day 1) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Day 1, (maximum 2.0 Mg)) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (Day 1) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (Days 1-5) (View Prednisone Review and Prednisone Label ), METHOTREXATE (Day 1) (View Methotrexate Review and Methotrexate Label ), ARA C (Day 1) (View Ara-c Review and Ara-c Label ), DEXAMETHASONE (Day 1) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6754046-9 | Thrombophlebitis Superficial
Adverse event was reported on May 21, 2010 by a Female patient taking Campath (View Usage) (Dosage: Total Daily Dose: 12 Mg) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 37 years of age, weighting 134.5 lb, Patient had the following side effects: thrombophlebitis superficial. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), NORTREL 7/7/7 (View Nortrel 7/7/7 Review and Nortrel 7/7/7 Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), BENAZEPRIL HYDROCHLORIDE (As Used: 10/12.5 Mg) (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), LUNESTA (View Lunesta Review and Lunesta Label ), ZOFRAN (View Zofran Review and Zofran Label ).

6732139-X | Atrial Fibrillation
on May 04, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), pruritus and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with SOLU MEDROL (As Used: 1 G) (View Solu-medrol Review and Solu-medrol Label ), CYMBALTA (Total Daily Dose: 20 Mg) (View Cymbalta Review and Cymbalta Label ), PREVACID (As Used: 30 Mg) (View Prevacid Review and Prevacid Label ), CLARITIN (Total Daily Dose: 10 Mg) (View Claritin Review and Claritin Label ), XANAX (View Xanax Review and Xanax Label ), HYDROXYZINE (Q 4-6 Hrs) (View Hydroxyzine Review and Hydroxyzine Label ). Patient was hospitalized.

6731644-X | Atrial Fibrillation
on May 04, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), pruritus and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with SOLU MEDROL (As Used: 1 G) (View Solu-medrol Review and Solu-medrol Label ), CYMBALTA (Total Daily Dose: 20 Mg) (View Cymbalta Review and Cymbalta Label ), PREVACID (As Used: 30 Mg) (View Prevacid Review and Prevacid Label ), CLARITIN (Total Daily Dose: 10 Mg) (View Claritin Review and Claritin Label ), XANAX (View Xanax Review and Xanax Label ), HYDROXYZINE (Q 4-6 Hrs) (View Hydroxyzine Review and Hydroxyzine Label ). Patient was hospitalized.

6729765-0 | Anti-thyroid Antibody Positive, Caesarean Section, Herpes Simplex, Hyperthyroidism, Neutropenia, Parathyroid Gland Enlargement, Pregnancy, Pregnancy Induced Hypertension
Patient was taking Campath (View Usage). Patient had the following side effects: anti-thyroid antibody positive, caesarean section, herpes simplex (What is herpes simplex?), hyperthyroidism, neutropenia, parathyroid gland enlargement, pregnancy (What is pregnancy?), pregnancy induced hypertension on May 04, 2010 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 189.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), ZOFRAN (View Zofran Review and Zofran Label ), ADVIL (View Advil Review and Advil Label ), NUVIGIL (View Nuvigil Review and Nuvigil Label ), VALTREX (View Valtrex Review and Valtrex Label ), METOPROLOL TARTRATE (Approximately 200 Mg) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6721244-X | Headache, Intracranial Hypotension
Adverse event was reported on Apr 30, 2010 by a Male patient taking Campath (View Usage) (Dosage: 2 Cycles C-chop, On Day 1 Every 3 Weeks) was diagnosed with angioimmunoblastic t-cell lymphoma, stem cell transplant and. Location: UNITED STATES , 51 years of age, After Campath was administered, patient had the following side effects: headache (What is headache?), intracranial hypotension. During the same period patient was treated with FLUDARABINE PHOSPHATE (On Days -4 And -3 Pre-transplant) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), PREDNISONE (Days 1-5 Per C-chop Cycle Every 3 Weeks) (View Prednisone Review and Prednisone Label ), DOXORUBICIN HCL (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (2 Cycles As Part Of Hyper-c-hidam) (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (As Used: 12.5 Mg) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6712593-X | Pain
on Apr 05, 2010 Female patient from UNITED STATES , 43 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?). Campath dosage: Had 3 Doses.

6711222-9 | Subdural Haematoma
on Apr 22, 2010 Female patient from UNITED STATES , 51 years of age, weighting 176.4 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). Patient had the following side effects: subdural haematoma. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with ZANAFLEX (View Zanaflex Review and Zanaflex Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), AMITIZA (Total Daily Dose: 48 ?g) (View Amitiza Review and Amitiza Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), LUNESTA (View Lunesta Review and Lunesta Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), MIRALAX (View Miralax Review and Miralax Label ), BENEFIBER (View Benefiber Review and Benefiber Label ).

6709176-4 | Back Pain, Nephrolithiasis, Vomiting
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: back pain (What is back pain?), nephrolithiasis, vomiting on Apr 21, 2010 from UNITED STATES Additional patient health information: Male patient , 28 years of age, weighting 174.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Campath dosage: Total Daily Dose: 12 Mg. Patient was hospitalized.

6704071-9 | Chills
Adverse event was reported on Mar 18, 2010 by a Male patient taking Campath (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: chills.

6703720-9 | Anxiety, Cytomegalovirus Infection, Heart Rate Increased, Hepatic Enzyme Increased, Hepatitis C, Platelet Count Decreased, Splenomegaly
on Apr 12, 2010 Female patient from UNITED STATES , 46 years of age, weighting 194.0 lb, was diagnosed with renal transplant and was treated with Campath (View Usage). Patient had the following side effects: anxiety (What is anxiety?), cytomegalovirus infection (What is cytomegalovirus infection?), heart rate increased, hepatic enzyme increased, hepatitis c (What is hepatitis c?), platelet count decreased, splenomegaly. Campath dosage: 2 Doses Given: During Kidney Transplant And Again On Day +1.

6703715-5 | Atrial Fibrillation
on Apr 14, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), pruritus and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with SOLU MEDROL (As Used: 1 G) (View Solu-medrol Review and Solu-medrol Label ), CYMBALTA (Total Daily Dose: 20 Mg) (View Cymbalta Review and Cymbalta Label ), PREVACID (As Used: 30 Mg) (View Prevacid Review and Prevacid Label ), CLARITIN (Total Daily Dose: 10 Mg) (View Claritin Review and Claritin Label ), XANAX (View Xanax Review and Xanax Label ), HYDROXYZINE (Q 4-6 Hrs) (View Hydroxyzine Review and Hydroxyzine Label ).

6702104-7 | Injection Site Erythema, Injection Site Inflammation, Injection Site Pain, Injection Site Swelling, Injection Site Warmth
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: injection site erythema, injection site inflammation, injection site pain, injection site swelling, injection site warmth on Mar 09, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with chronic lymphocytic leukaemia and. Campath dosage: Total Daily Dose: 3 Mg.

6702054-6 | Blood Count Abnormal, Chills, Fatigue, Pain In Extremity
Adverse event was reported on Mar 17, 2010 by a Male patient taking Campath (View Usage) (Dosage: Total Daily Dose: 3 Mg) was diagnosed with chronic lymphocytic leukaemia stage 4, infection prophylaxis, antiviral prophylaxis and. Location: UNITED STATES , 62 years of age, weighting 160.9 lb, Patient had the following side effects: blood count abnormal, chills, fatigue, pain in extremity. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), VISTARIL (View Vistaril Review and Vistaril Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), DIFLUCAN (Total Daily Dose: 100 Mg) (View Diflucan Review and Diflucan Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

6700146-9 | Injection Site Reaction
on Feb 10, 2010 Male patient from UNITED STATES , 83 years of age, was diagnosed with aplastic anaemia and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: injection site reaction. Campath dosage: Total Daily Dose: 3 Mg.

6700144-5 | Platelet Count Decreased
on Mar 01, 2010 Male patient from UNITED STATES , 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Campath dosage: Total Daily Dose: 3 Mg.

6698248-9 | Anxiety, Cytomegalovirus Infection, Heart Rate Increased, Hepatic Enzyme Increased, Hepatitis C, Platelet Count Decreased, Splenomegaly
Patient was taking Campath (View Usage). Patient had the following side effects: anxiety (What is anxiety?), cytomegalovirus infection (What is cytomegalovirus infection?), heart rate increased, hepatic enzyme increased, hepatitis c (What is hepatitis c?), platelet count decreased, splenomegaly on Apr 12, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 194.0 lb, was diagnosed with renal transplant and. Campath dosage: 2 Doses Given: During Kidney Transplant And Again On Day +1.

6698199-X | Thrombotic Thrombocytopenic Purpura
Adverse event was reported on Mar 29, 2010 by a Male patient taking Campath (View Usage) (Dosage: Day -2, -1,0 / First Cycle 3, 10 , 20 Mg) . Location: UNITED STATES , 55 years of age, After Campath was administered, patient had the following side effects: thrombotic thrombocytopenic purpura. During the same period patient was treated with PREDNISONE TAB (First Cycle) (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOPHOSPHAMIDE (First Cycle 750 Mg/m2) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (First Cycle) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Second Cycle) (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6689726-7 | Atrial Fibrillation, Blood Thyroid Stimulating Hormone Decreased, Fatigue, Myelitis Transverse, Palpitations, Tachycardia
on Apr 14, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), pruritus and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood thyroid stimulating hormone decreased, fatigue, myelitis transverse, palpitations, tachycardia. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with SOLU MEDROL (As Used: 1 G) (View Solu-medrol Review and Solu-medrol Label ), CYMBALTA (Total Daily Dose: 20 Mg) (View Cymbalta Review and Cymbalta Label ), PREVACID (As Used: 30 Mg) (View Prevacid Review and Prevacid Label ), CLARITIN (Total Daily Dose: 10 Mg) (View Claritin Review and Claritin Label ), XANAX (View Xanax Review and Xanax Label ), HYDROXYZINE (Q 4-6 Hrs) (View Hydroxyzine Review and Hydroxyzine Label ).

6687944-5 | Pneumonitis, Pulmonary Oedema
on Apr 07, 2010 Male patient from UNITED STATES , 22 years of age, weighting 125.7 lb, was diagnosed with renal transplant, blood pressure systolic decreased and was treated with Campath (View Usage). Patient had the following side effects: pneumonitis, pulmonary oedema. Campath dosage: 2 Hours Infusion Time. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DOPAMINE HCL (3 Mcg/kg/min) (View Dopamine Hcl Review and Dopamine Hcl Label ).

6687895-6 | Bronchopulmonary Aspergillosis, Enterococcal Bacteraemia, Liver Disorder, Melaena, Pancytopenia, Pyrexia, T-cell Lymphoma
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: bronchopulmonary aspergillosis, enterococcal bacteraemia, liver disorder, melaena, pancytopenia, pyrexia, t-cell lymphoma on Mar 29, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, . Campath dosage: . During the same period patient was treated with PREDNISONE (Day 1 - 5 Of First Chop Cycle) (View Prednisone Review and Prednisone Label ), CYCLOPHOSPHAMIDE (Day 1 Of First Chop Cycle) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Day 1 Of First Chop Cycle) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Day 1 Of First Chop Cycle) (View Vincristine Review and Vincristine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ARA C (View Ara-c Review and Ara-c Label ). Patient was hospitalized.

6686651-2 | Hyperthyroidism, Thyrotoxic Crisis
Adverse event was reported on Apr 05, 2010 by a Female patient taking Campath (View Usage) (Dosage: Total Daily Dose: 12 Mg) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 34 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: hyperthyroidism, thyrotoxic crisis. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ADVIL (View Advil Review and Advil Label ), NUVIGIL (View Nuvigil Review and Nuvigil Label ), VALTREX (View Valtrex Review and Valtrex Label ), METOPROLOL TARTRATE (Approximately 200 Mg) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6686280-0 | Hypoaesthesia, Neuropathy Peripheral
on Apr 07, 2010 Female patient from UNITED STATES , 77 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath (View Usage). Patient had the following side effects: hypoaesthesia, neuropathy peripheral. Campath dosage: .

6679217-1 | Bronchopulmonary Aspergillosis, Enterococcal Bacteraemia, Liver Disorder, Melaena, Pancytopenia, Pyrexia, T-cell Lymphoma
on Mar 29, 2010 Male patient from UNITED STATES , 70 years of age, was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: bronchopulmonary aspergillosis, enterococcal bacteraemia, liver disorder, melaena, pancytopenia, pyrexia, t-cell lymphoma. Campath dosage: . During the same period patient was treated with PREDNISONE TAB (Day 1 - 5 Of First Chop Cycle) (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOPHOSPHAMIDE (Day 1 Of First Chop Cycle) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Day 1 Of First Chop Cycle) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Day 1 Of First Chop Cycle) (View Vincristine Review and Vincristine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ARA C (View Ara-c Review and Ara-c Label ). Patient was hospitalized.

6679107-4 | Cerebral Ischaemia, Peripheral Sensory Neuropathy
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral ischaemia, peripheral sensory neuropathy on Mar 29, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, . Campath dosage: Dose Escalation Day -1 Before The First Chop-c Course. During the same period patient was treated with PREDNISONE TAB (6 Cycles Of C-chop Every 21 Days) (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOPHOSPHAMIDE (6 Cycles Of C-chop Every 21 Days) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (6 Cycles Of C-chop Every 21 Days) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (6 Cycles Of C-chop Every 21 Days) (View Vincristine Review and Vincristine Label ), METHOTREXATE (On Day 1 Of Each Chop-c Course) (View Methotrexate Review and Methotrexate Label ), ARA C (On Day 1 Of Each Chop-c Course) (View Ara-c Review and Ara-c Label ), DEXAMETHASONE (On Day 1 Of Each Chop-c Course) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6679091-3 | Melaena, Presyncope, Pyrexia
Adverse event was reported on Mar 29, 2010 by a Male patient taking Campath (View Usage) (Dosage: Dose Escalation) was diagnosed with viral infection (What is viral infection?), fungal infection (What is fungal infection?) and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: melaena, presyncope, pyrexia. During the same period patient was treated with PREDNISONE TAB (Cycle 1 Of A-chop) (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOPHOSPHAMIDE (Cycle 1 Of A-chop) (View Cyclophosphamide Review and Cyclophosphamide Label ), ADRIAMYCIN PFS (Cycle 1 Of A-chop) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VINCRISTINE (Cycle 1 Of A-chop) (View Vincristine Review and Vincristine Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), SPORANOX (View Sporanox Review and Sporanox Label ). Patient was hospitalized.

6678956-6 | Diabetes Mellitus, Hyperglycaemia, Hypertension
on Mar 29, 2010 Female patient from UNITED STATES , 67 years of age, was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: diabetes mellitus, hyperglycaemia, hypertension. Campath dosage: Dose Escalation. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ARA C (View Ara-c Review and Ara-c Label ). Patient was hospitalized.

6677236-2 | Back Pain, Nephrolithiasis, Vomiting
on Mar 29, 2010 Male patient from UNITED STATES , 28 years of age, weighting 176.4 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), nephrolithiasis, vomiting. Campath dosage: Total Daily Dose: 12 Mg. Patient was hospitalized.

6667485-1 | Abdominal Pain, Bile Duct Obstruction, Cholangitis Acute, Device Dislocation, Hepatic Function Abnormal
Patient was taking Campath (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bile duct obstruction, cholangitis acute, device dislocation, hepatic function abnormal on Mar 19, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 187.4 lb, was diagnosed with chronic lymphocytic leukaemia, viral test positive and. Campath dosage: Total Daily Dose: 30 Mg. During the same period patient was treated with VALCYTE (View Valcyte Review and Valcyte Label ), BISEPTOL (View Biseptol Review and Biseptol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MILURIT (View Milurit Review and Milurit Label ), HELICID (View Helicid Review and Helicid Label ). Patient was hospitalized.

6667484-X | Cough, Dizziness, Infection, Pyrexia, Rhinorrhoea, Syncope, Tachyarrhythmia, Urinary Tract Infection
Adverse event was reported on Mar 19, 2010 by a Female patient taking Campath (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia and. Location: GERMANY , 74 years of age, weighting 127.9 lb, After Campath was administered, patient had the following side effects: cough, dizziness (What is dizziness?), infection (What is infection?), pyrexia, rhinorrhoea, syncope, tachyarrhythmia, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6667464-4 | Hypersensitivity, Liver Function Test Abnormal, Pneumonia, Pyrexia
on Mar 16, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, liver function test abnormal, pneumonia (What is pneumonia?), pyrexia. Campath dosage: As Used: 30 Mg. During the same period patient was treated with RITUXIMAB (As Used: 375 Mg/m2) (View Rituximab Review and Rituximab Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MEPRON (View Mepron Review and Mepron Label ), LOTREL (View Lotrel Review and Lotrel Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6667430-9 | Blood Potassium Decreased, Grand Mal Convulsion, Hypertension, Hyponatraemia, Pyelonephritis
on Mar 15, 2010 Male patient from UNITED STATES , child 11 years of age, was diagnosed with renal transplant, prophylaxis and was treated with Campath (View Usage). Patient had the following side effects: blood potassium decreased, grand mal convulsion, hypertension, hyponatraemia, pyelonephritis. Campath dosage: Unit Dose: 0.3 Mg/kg. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), SOLU MEDROL (10 Mg/kg, (max-500 Mg)) (View Solu-medrol Review and Solu-medrol Label ), ACETAMINOPHEN (15 Mg/kg (max-650 Mg)) (View Acetaminophen Review and Acetaminophen Label ), BENADRYL (1 Mg/kg (max-50mg)) (View Benadryl Review and Benadryl Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6663368-1 | Cough, Dizziness, Infection, Pyrexia, Rhinorrhoea, Syncope, Tachyarrhythmia, Urinary Tract Infection
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: cough, dizziness (What is dizziness?), infection (What is infection?), pyrexia, rhinorrhoea, syncope, tachyarrhythmia, urinary tract infection (What is urinary tract infection?) on Mar 19, 2010 from GERMANY Additional patient health information: Female patient , 74 years of age, weighting 127.9 lb, was diagnosed with chronic lymphocytic leukaemia and. Campath dosage: . During the same period patient was treated with PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6663366-8 | Anaphylactic Shock, Circulatory Collapse, Urinary Incontinence
Adverse event was reported on Mar 19, 2010 by a Male patient taking Campath (View Usage) (Dosage: Month 0) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 31 years of age, weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, circulatory collapse, urinary incontinence (What is urinary incontinence?). During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6663365-6 | Abdominal Pain, Bile Duct Obstruction, Cholangitis Acute, Device Dislocation, Hepatic Function Abnormal
on Mar 19, 2010 Male patient from UNITED STATES , 63 years of age, weighting 187.4 lb, was diagnosed with chronic lymphocytic leukaemia, viral test positive and was treated with Campath (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bile duct obstruction, cholangitis acute, device dislocation, hepatic function abnormal. Campath dosage: Total Daily Dose: 30 Mg. During the same period patient was treated with VALCYTE (View Valcyte Review and Valcyte Label ), BISEPTOL (View Biseptol Review and Biseptol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MILURIT (View Milurit Review and Milurit Label ), HELICID (View Helicid Review and Helicid Label ). Patient was hospitalized.

6660554-1 | Hypersensitivity, Liver Function Test Abnormal, Pneumonia, Pyrexia
on Mar 16, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: hypersensitivity, liver function test abnormal, pneumonia (What is pneumonia?), pyrexia. Campath dosage: As Used: 30 Mg. During the same period patient was treated with RITUXIMAB (As Used: 375 Mg/m2) (View Rituximab Review and Rituximab Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MEPRON (View Mepron Review and Mepron Label ), LOTREL (View Lotrel Review and Lotrel Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6655146-4 | Constipation, Febrile Neutropenia
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), febrile neutropenia on Mar 16, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent and. Campath dosage: As Used: 30 Mg. During the same period patient was treated with RITUXIMAB (As Used: 375 Mg/m2) (View Rituximab Review and Rituximab Label ), FLOMAX (View Flomax Review and Flomax Label ), AVODART (View Avodart Review and Avodart Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), MEPRON (View Mepron Review and Mepron Label ). Patient was hospitalized.

6652947-3 | Grand Mal Convulsion, Hypertension, Hyponatraemia, Pyelonephritis
Adverse event was reported on Mar 15, 2010 by a Male patient taking Campath (View Usage) (Dosage: Unit Dose: 0.3 Mg/kg) was diagnosed with renal transplant, prophylaxis and. Location: UNITED STATES , child 11 years of age, Patient had the following side effects: grand mal convulsion, hypertension, hyponatraemia, pyelonephritis. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), SOLU MEDROL (10 Mg/kg, (max-500 Mg)) (View Solu-medrol Review and Solu-medrol Label ), ACETAMINOPHEN (15 Mg/kg (max-650 Mg)) (View Acetaminophen Review and Acetaminophen Label ), BENADRYL (1 Mg/kg (max-50mg)) (View Benadryl Review and Benadryl Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6648150-3 | Subdural Haematoma
on Mar 10, 2010 Female patient from UNITED STATES , 51 years of age, weighting 176.4 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: subdural haematoma. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with ZANAFLEX (View Zanaflex Review and Zanaflex Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), AMITIZA (Total Daily Dose: 48 ?g) (View Amitiza Review and Amitiza Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), LUNESTA (View Lunesta Review and Lunesta Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), MIRALAX (View Miralax Review and Miralax Label ), BENEFIBER (View Benefiber Review and Benefiber Label ).

6647646-8 | Blister, Erythema, Pain In Extremity, Secretion Discharge
on Mar 23, 2010 Male patient from UNITED STATES , weighting 213.0 lb, was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: blister, erythema, pain in extremity, secretion discharge. Campath dosage: Renal Transplant. Patient was hospitalized.

6647645-6 | Impaired Healing, Joint Swelling, Joint Warmth, Pain In Extremity, Skin Ulcer
Patient was taking Campath (View Usage). Patient had the following side effects: impaired healing, joint swelling, joint warmth, pain in extremity, skin ulcer on Mar 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 218.0 lb, . Campath dosage: Renal Transplant. Patient was hospitalized.